Christopher Ryan Sullivan, CFO: Avalo Therapeutics AVTX Sell · Filed 04/03

Trade details

Type: Insider sale
Amount: $125,871.57
Shares · price: 7,479 sh · $16.83 a share
Held after: 25,318 sh
Stock: Avalo Therapeutics AVTX
Person: Christopher Ryan SullivanCFO
Trade date: 26/04/01
Filed: 26/04/03
Days to filing: 2 days

Sold 22.8% of holdings

Share of holding sold: 22.8%

Avalo Therapeutics trades, last 26 weeks

What else happened in Avalo Therapeutics around then

Filed or reported within 30 days of the trade day · 03/02~05/01

Christopher Ryan Sullivan's recent trades

Christopher Ryan SullivanCFO
Planned saleAvalo Therapeutics
Planned sale
Avalo Therapeutics
AVTX
$622.2K
31,031 sh
$622.2K
Filed 08/18
Traded 08/18
Christopher Ryan SullivanCFO
Planned sale10b5-1 planAvalo Therapeutics
Planned sale10b5-1 plan
Avalo Therapeutics
AVTX
$1.4M
70,709 sh
$1.4M
Filed 08/17
Traded 08/17
Christopher Ryan SullivanCFO
Planned saleAvalo Therapeutics
Planned sale
Avalo Therapeutics
AVTX
$74.8K
3,749 sh
$74.8K
Filed 08/17
Traded 08/17
Christopher Ryan SullivanCFO
Sell10b5-1 planAvalo Therapeutics
Sell10b5-1 plan
Avalo Therapeutics
AVTX
$448.8K
18,606 sh
$448.8K
Filed 05/11
Traded 05/07
Christopher Ryan SullivanCFO
Planned sale10b5-1 planAvalo Therapeutics
Planned sale10b5-1 plan
Avalo Therapeutics
AVTX
$405.8K
18,606 sh
$405.8K
Filed 05/07
Traded 05/07